Novovartalon Glucosamine Meloxicam 15 Envelopes

NOVOVARTALON Formulation and Dosage Form Each sachet contains: Glucosamine Sulfate polycrystalline equivalent to 1,500 mg of glucosamine sulfate Meloxicam 15 mg Dosage and administration NOVOVARTALON ® is administered orally. It is particularly useful in patients diagnosed with osteoarthritis in the acute phase is accompanied by pain and / or stiffness. INDICATIONS: Condroprotector and analgesic. Glucosamine has been classified by the International League Against Rheumatism (ILAR) and the EULAR (European League Against Rheumatism) as a symptomatic slow-acting drug for osteoarthritis (SYSADOA), but also for its therapeutic action, also it has been classified as disease modifying drug stops the progression of osteoarthritis (DMOAD). Meloxicam is a non steroidal anti-inflammatory selective COX-2, indicated in the treatment of inflammation and pain present in osteoarthritis (degenerative joint disease), periarthritis of shoulder, hip and knee. Therefore, the association NOVOVARTALON® glucosamine-Meloxicam is clear indication in the population with the following risk factors: age 50 years, obesity, people who play high-impact sports to the joints, patients with a history of trauma or fractures involving the joints. The chondroprotective and restorative effect of glucosamine, coupled with its symptomatic action, modifies the evolution of osteoarthritis, which added to the anti-inflammatory and analgesic action of meloxicam significantly relieve pain, both at rest and during movement, improving mobility short and medium term. The association of meloxicam NOVOVARTALON® glucosamine provides a quick symptomatic action and initiates the process of suspending the progression of osteoarthritis.